← Back to Program
Fredric Schiffer

Fredric Schiffer

Harvard Medical School, Boston, Massachusetts, USA / McLean Hospital, Belmont, Massachusetts, USA / MindLigh, LLC, Newton, Massachusetts, USA
Tuesday, October 13 · Poster Session 1 · Mission Bay Room
Poster
Testing Experience Transfer Between Organisms: A Dimensional Framework and an Empirical Proposal

Space and time are irreducible dimensions of nature — measurable but not derivable from anything more fundamental. I propose that life and experience are also irreducible dimensions, and that this recognition dissolves both the hard problem of consciousness and the hard problem of life (Schiffer, in review). Physics has failed to derive consciousness and life from lower-level processes because they are not derivable; they are foundational. Reframing them as dimensions transforms both problems into tractable questions about the conditions under which physical organization gains access to the life and experiential dimensions. Four convergent arguments support this framework. First, the dimensional argument: life and experience meet the same criteria for foundational status as space and time — causally real, irreducible, and known through inhabitation as well as external observation. We do not derive space from anything; we inhabit it. The same is true of experience. Second, the AI argument: information processing of extraordinary sophistication does not generate experience, providing an existence proof that something beyond computation is required for access to the experiential dimension. Third, the Now Problem: the present moment — the most certain datum of experience — has no place in the formalism of physics. This is not a gap awaiting closure but a structural absence pointing to a dimension physics does not contain. Fourth, thirty-three years of clinical evidence from hemispheric stimulation indicating that a single brain contains two selves with independent access to the experiential dimension, with therapeutic outcomes for anxiety, depression, and opioid use disorder sufficient to earn FDA Breakthrough Device Designation (Schiffer 2026b). The relationship between physical and experiential dimensions is asymmetric. Physical dimensions constrain what can be experienced but experience does not alter spacetime. The asymmetry places experience in the right ontological category while explaining why no physical instrument has ever directly measured an experience. Experience is nonetheless inferable from behavior: the creature itself reports its experiential state through behavior. The Subjective Field is proposed as the physical mechanism linking the life dimension to the experiential dimension, transforming coherent neural information into feelable information actualized by the self. From the unified life-experience dimension emerges a candidate fifth fundamental force — the Force of Experience (Schiffer 2026a) — whose causal reality is evidenced by every artifact of human civilization, including the instruments built to study the brain. A distinctive empirical implication builds on Nicolelis and colleagues, who showed that an encoder rat's cortical activity, transmitted to a decoder rat, could guide the decoder's behavioral choices about 65–70% of the time. The proposed extension asks whether inducing a powerful hedonic state in the encoder rat — through opioid administration — alters its neural emissions sufficiently to make the decoder bar-press for more signals. If the decoder rat works to receive more signal, it is most parsimoniously interpreted as experiencing pleasure derived from the encoder's hedonic state — a direct behavioral test of experience transfer between organisms. The dimensional framework does not solve the hard problems by finding a better mechanism; it dissolves them by recognizing that dimensions do not require mechanisms — they require recognition.

About the speaker

Fredric Schiffer, MD, is a psychiatrist, researcher, and inventor who has spent more than three decades on the faculty of Harvard Medical School and as a researcher at McLean Hospital. He maintains a private practice in Newton, MA. His career has centered on understanding how the two brain hemispheres shape emotion and behavior — a line of work that led him to develop Dual-Brain Psychology (DBP) and noninvasive treatment approaches for anxiety, depression, PTSD, and opioid use disorder. His research in transcranial photobiomodulation has led to an FDA Breakthrough Designation. He is also developing a theoretical framework that treats life and experience as irreducible dimensions of nature, with recent publications in Biological Theory and Frontiers journals. He is founder and CEO of MindLight LLC.